Showing results (761-770 of 1,154) with videos related to

Sort By:
Pageof 116
BMJ Open|March 31, 2022
Efficacy and safety of an orally administered DGAT2 inhibitor alone or coadministered with a liver-targeted ACC inhibitor in adults with non-alcoholic steatohepatitis (NASH): rationale and design of the phase II, dose-ranging, dose-finding, randomised, placebo-controlled MIRNA (Metabolic Interventions to Resolve NASH with fibrosis) studyNeeta B Amin, Amanda Darekar, Quentin M Anstee, et al.
Journal of Digestive Diseases|June 30, 2015
miR-30c and miR-193 are a part of the TGF-β-dependent regulatory network controlling extracellular matrix genes in liver fibrosisSanchari Roy, Fabian Benz, David Vargas Cardenas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2008
Gp130 signaling promotes development of acute experimental colitis by facilitating early neutrophil/macrophage recruitment and activationLeif E Sander, Florian Obermeier, Uta Dierssen, et al.
International Journal of Clinical and Experimental Pathology|April 11, 2013
Met-CCL5 modifies monocyte subpopulations during liver fibrosis regressionMiriam K Stock, Linda Hammerich, Nicole T do O, et al.
Gut|April 4, 2020
Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensationSofia Monteiro, Josephine Grandt, Frank Erhard Uschner, et al.
Scientific Reports|June 21, 2018
The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic ratsPhilipp Schwabl, Ksenia Brusilovskaya, Paul Supper, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 13, 2025
Metabolic Signatures of Acinetobacter baumannii and Klebsiella pneumoniae Infections in Acute-on-chronic Liver FailureCamilla Cadoli, Sania Arif, Wibke Ballhorn, et al.
Hepatology International|April 5, 2022
Aspirin improves transplant-free survival after TIPS implantation in patients with refractory ascites: a retrospective multicentre cohort studyLeon Louis Seifert, Philipp Schindler, Lukas Sturm, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 20, 2025
Chronic kidney disease does not influence response to terlipressin in hepatorenal syndrome - acute kidney injuryFrank Erhard Uschner, Eva Maria Schleicher, Moritz Passenberg, et al.
Alimentary Pharmacology & Therapeutics|December 4, 2025
Serum Villin-1-A Novel Marker of Gut Barrier Damage in Acutely Decompensated Cirrhosis: A Cohort Study and ValidationDavid Tornai, Boglarka Balogh, Aniko Csillag, et al.
Pageof 116